Pharma

Your Article Summary

See Latest Articles

Shire to Present Important Study Findings on its ADHD Treatments at a Major Psychiatric Meeting on October
Shire, 10/30/09

Shire plc, the global specialty biopharmaceutical company, announced that it will present key scientific data on its Attention–Deficit/Hyperactivity Disorder treatments, INTUNIV Extended Release Tablets, VYVANSE (lisdexamfetamine dimesylate) Capsules CII, and DAYTRANA (methylphenidate transdermal system) CII, at a national meeting of psychiatrists to be held October– November.

Today in Conferences/Meetings...keeping you current

Receive free subspecialty "5-minute updates" via email

ImmunoGen, Inc. Announces Clinical Data Presentations on Three TAP Compounds at Upcoming ASH Annual Meeting and Exposition
ImmunoGen, Inc., 11/25/09

AMA meeting: Nap time mandate for on-call residents rejected
American Medical News , 11/25/09

AMA meeting: Delegate vote refines AMA stance on system reform
American Medical News , 11/25/09

 See all of Conferences/Meetings